NIH-funded research R01 grant

Targeted antibiotic therapy for Shigella in young children in low-resource settings

Official title: Targeted antibiotic therapy for Shigella among children in low-resource settings

Funded at Emory University · NIH-11543039 · Data updated 2026-11-12

A new approach aims to correctly identify Shigella infections in young children with diarrhea and treat them with targeted antibiotics to improve outcomes and reduce antibiotic resistance.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionEmory University
NIH-funded
Lab location1 site (Atlanta, United States)
Project startAugust 7, 2024
Project endJune 30, 2029
Funding year2026
Award (this year)$136,169
NIH project number3R01AI185140-03S1
Project IDNIH-11543039 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are children under 5 years old hospitalized with diarrhea in low-resource settings who can be tested for Shigella and monitored for antibiotic response.

Less likely to help

Some children with non-Shigella diarrhea or viral infections may not benefit from antibiotic targeting in this study.

What this research studies

This research will enroll children with diarrhea in low-resource settings to understand when antibiotics are truly needed for Shigella infections. It plans to use biomarker-based strategies to quickly identify Shigella at the point of care and guide treatment. The study also aims to design population-level approaches to narrow antibiotic use to confirmed Shigella cases, helping preserve antibiotics for those who need them most. The work will be conducted through a prospective cohort of hospitalized children and will consider outcomes related to diarrhea severity and resistance patterns.

Why it matters

Potential benefit: If successful, this project could improve recovery from diarrhea in children while reducing unnecessary antibiotic use and slowing antimicrobial resistance.

How similar studies have gone: Previous work suggests that accurate, rapid identification of Shigella can improve treatment decisions, but this specific biomarker-based, population-level strategy in low-resource settings is novel.

Where this research is happening

  • Emory University
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Rogawski Mcquade, Elizabeth Tacket — Emory University
  • Study coordinator: Rogawski Mcquade, Elizabeth Tacket

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.